CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

Bibliographic Details
Main Authors: Paul W Noble, Luca Richeldi, David A Lynch, Steven Greenberg, THEODORE F REISS, Zoran Popmihajlov, Donna J Sutherland, Gerald S Horan, Atalanta Ghosh
Format: Article
Language:English
Published: BMJ Publishing Group 2022-01-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/9/1/e001060.full